Clinical Trial Update: Evaluation of the Safety, Tolerability, and Efficacy of MDGN-002 in Adults With Moderate to Severe Active Crohn's Disease or Ulcerative Colitis [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating MDGN-002 in adults with Crohn's disease or ulcerative colitis has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease
• Ulcerative Colitis

Drugs mentioned

• MDGN-002

Snippet

Sponsor: Avalo Therapeutics, Inc. | Conditions: Crohn Disease, Ulcerative Colitis | Phase 1 | Status: TERMINATED | Results posted: 2024-02-26